Medical Nutrition USA Introduces New Pro-Stat(R) AWC With Citrulline for Increased Effectiveness in Wound Care
April 29 2009 - 1:45PM
Marketwired
Medical Nutrition USA, Inc. (NASDAQ: MDNU), a developer and
distributor of proprietary, nutrition medicine products, announced
the introduction of Pro-Stat� AWC with Citrulline. The product,
which is an enhanced formulation of Pro-Stat� AWC, is designed for
patients in long-term care facilities with advanced wounds,
primarily pressure ulcers.
Pressure ulcers, also know as bedsores, can significantly
diminish quality of life and require substantial cost to remedy.
Also, statistics show the incidence of bedsores to be as high as
one-in-four among long-term care residents, with a price tag for
treatment of $1.3 billion nationally.
Pro-Stat� AWC with Citrulline is the only wound care supplement
with Citrulline, an amino acid that safely and effectively
increases Arginine levels to produce nitric oxide needed for wound
healing. Nitric oxide is used by the inner lining of blood vessels
to relax the surrounding smooth muscle, resulting in a widening of
blood vessels and increased blood flow to the wound.
A clinical study, conducted by S. Kwon Lee MD, FACS, and
published in the journal Advances in Skin & Wound Care in 2006,
of long-term care residents with pressure ulcers showed a 96%
improvement in healing rates among those residents that received
standard care plus Pro-Stat� compared to a control group that
received standard care plus a placebo.
"Pro-Stat� AWC with Citrulline is an even more effective
treatment option for patients with pressure ulcers," said Frank A.
Newman, Medical Nutrition USA's Chairman and Chief Executive
Officer. "This important addition to the Pro-Stat� product line
demonstrates Medical Nutrition USA's continuing dedication to
developing significant and highly-effective new products on a
timely basis."
About Medical Nutrition USA, Inc.
Medical Nutrition USA, Inc. (NASDAQ: MDNU), is a growing
supplier of a line of engineered and clinically tested medical
nutritional supplements aimed primarily at nursing homes, assisted
living communities and dialysis markets nationwide. The company's
strong performance is the result of its significant and growing
share in U.S. and Canadian institutional markets that is
accelerated by ongoing, successful new-product development and
introductions. Find more on Medical Nutrition at www.mdnu.com.
This press release contains forward-looking statements that are
subject to certain risks and uncertainties. Although we believe
that the expectations reflected in any of our forward-looking
statements are reasonable, actual results could differ materially
from those projected or assumed. Risks and uncertainties that could
cause or contribute to such material difference include, but are
not limited to, general economic conditions, changes in customer
demand, changes in trends in the nursing home, renal care, health
food and bariatric surgery markets, changes in competitive pricing
for products, and the impact of our competitors' new product
introductions. Our future financial condition and results of
operations, as well as any forward-looking statements are subject
to change and inherent risk and uncertainties. Other important
factors that may cause actual results to differ materially from
those expressed in forward-looking statements is contained in the
Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year
ended January 31, 2009 as filed with the Securities and Exchange
Commission on April 24, 2009.
Contacts: Medical Nutrition USA, Inc. Frank J. Kimmerling Vice
President/CFO 800.221.0308 Email Contact Investor Relations Adam
Friedman 212.981.2529 x18 Email Contact
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Jul 2023 to Jul 2024